Trastuzumab Terminated Phase 2 Trials for HER-2 Positive Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00810017Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer